Impact of objective response (OR) on patient-reported outcomes (PRO) in   patients (pts) with advanced breast cancer (ABC) and a germline BRCA1/2   (gBRCA) mutation in the phase III EMBRACA trial

Titel:: Impact of objective response (OR) on patient-reported outcomes (PRO) in patients (pts) with advanced breast cancer (ABC) and a germline BRCA1/2 (gBRCA) mutation in the phase III EMBRACA trial
Dokumenttyp:: Meeting Abstract
Autor(en):: Fasching, P. A.; Quek, R. G. W.; Bhattacharyya, H.; Hurvitz, S. A.; Rugo, H. S.; Ettl, J.
Zeitschriftentitel:: Ann Oncol
Jahr:: 2019
Band / Volume:: 30 Suppl 3
Print-ISSN:: 0923-7534
TUM Einrichtung:: Frauenklinik und Poliklinik
BibTeX

Vorkommen: